英氏控股IPO：业绩增长疲态尽显用近4成收入营销、研发费用率<1% 除米粉外辅食全靠代工、频因品控问题遭控诉

Core Viewpoint - Ying's Holdings Group Co., Ltd. has submitted an IPO application to the Beijing Stock Exchange, aiming to raise 334 million yuan for various projects, despite showing signs of declining performance in recent years [1][3]. Financial Performance - Ying's Holdings reported revenue of 1.296 billion yuan in 2022, 1.758 billion yuan in 2023, and 1.974 billion yuan in 2024, with year-on-year growth rates of 37.35%, 35.67%, and 12.29% respectively [3]. - The company's net profit attributable to shareholders was 117 million yuan in 2022, 220 million yuan in 2023, and 211 million yuan in 2024, with growth rates of 64.91%, 87.67%, and a decline of 4.36% [3]. - In the first quarter of 2025, the company achieved a revenue of 540 million yuan, a year-on-year increase of 12.29%, and a net profit of 79 million yuan, up 4.73% [3]. Business Segmentation - In 2024, the revenue from infant complementary food reached 1.524 billion yuan, growing by 5.48% and accounting for 77% of total revenue [5]. - Revenue from infant hygiene products was 340 million yuan, up 31.28%, making up 17% of total revenue [5]. - Revenue from children's food was 95 million yuan, showing a significant increase of 159.7%, representing 5% of total revenue [5]. Production and Quality Control - Ying's Holdings relies heavily on contract manufacturing for its products, with only rice flour produced in-house, leading to potential quality control issues [2][10]. - The company has faced consumer complaints regarding product quality, with issues reported on platforms like Black Cat Complaints and Xiaohongshu [2][10]. - The production capacity utilization rates for rice flour, diapers, and other products were 72.53%, 85.06%, and 85.73% respectively, indicating a reliance on external manufacturers for most products [11]. Marketing and R&D Expenditure - The company allocated nearly 40% of its revenue to marketing, with sales expenses increasing significantly from 454 million yuan in 2022 to 721 million yuan in 2024 [8]. - In contrast, R&D expenses were relatively low, at 6 million yuan, 9 million yuan, and 17 million yuan for the years 2022 to 2024, with R&D expense ratios of 0.43%, 0.52%, and 0.87% respectively [8].